James Boy­lan snags $300M to hunt for biotech deals af­ter leav­ing SVB

The Santa Monica, CA-based biotech’s stock shot up early Friday on reports that it had agreed to a licensing deal with Hikma Pharmaceuticals on an experimental nasal spray to treat opioid overdoses.